Abstract
The application of phosphatidylcholine to the fat tissue of humans for aesthetic purposes has recently been in evidence, despite the sparse literature corroboration of this practice. The authors developed a new experimental model to study injection of substances in fat tissue in rabbits. The objective of this particular study was to verify the possible effects of phosphatidylcholine injected in the animals. The animal weight, the fat pad weight, the presence of inflammatory infiltrate, and fibrosis and necrosis at the application sites were observed. Two groups of rabbits received five weekly applications to the dorsal fat pad. The control group received saline solution 0.9%, and the study group received phosphatidylcholine. The removed fat tissue was evaluated 3, 7, 14, and 21 days after the fifth application was completed. The phosphatidylcholine group presented more intense inflammatory infiltrate and fibrosis than the control group (p = 0.05). Necrosis was not observed in any animal. There was no statistically significant difference with regard to the weights of the animal or the fat pad. On the basis of this study, the injection of phosphatidylcholine is relatively safe, but no effect was observed regarding the reduction of fat tissue volume. New studies with higher doses are needed to justify the clinical use of this substance.
Similar content being viewed by others
References
Ablon G, Rotunda AM: Treatment of lower eyelid fat pads using phosphatidylcholine: Clinical trial and review. Dermatol Surg 30:422–427, 2004
Agência Nacional de Vigilância Sanitária (ANVISA): Resolution number 30, January 8, 2003, D.O.U. of 01/09/2003
Aleynik SI, Leo MA, Aleynik MK, Lieber CS: Polyenylphosphatidylcholine protects against alcohol but not iron-induced oxidative stress in liver. Alcohol Clin Exp Res 24:196–206, 2000
Barone R, Pavaux C, Bliu PC, Cuq P: Atlas d’anatomie du lapin. Masson et Cie, êditeurs, Paris, 1973
Brook JG, Linn S, Aviram M: Dietary soy lecithin decreases plasma triglyceride levels and inhibits collagen-and ADP-induced platelet aggregation. Biochem Med Metab Biol 35:31–39, 1986
Canty D, Zeisel SH: Lecithin and choline in human health and disease. Nutr Rev 52:327–339, 1994
Chung S, Moriyama T, Uezu E, Uezu K, Hirata R, Yohena N, Masuda Y, Kokubu T, Yamamoto S: Administration of phosphatidylcholine increases brain acetylcholine concentration and improves memory in mice with dementia. J Nutr 125:1484–1489, 1995
Cross NL: Phosphatidylcholine enhances the acrossomal responsiveness of human sperm. J Androl 15:484–488, 1994
Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ: Classification of chronic hepatitis: Diagnosis, grading, and staging. Hepatology 19:1513–1520, 1994
Dudman NPB, Wilcken DEL, Wang J, Lynch JF, Macey D, Lundberg P: Disordered methionine homocysteine metabolism in premature vascular disease: Its occurrence, cofactor therapy, and enzymology. Arterioscler Thromb 13:1253–1260, 1993
Goshal AK, Farber E: The induction of liver cancer by dietary deficiency of choline and methionine without added carcinogens. Carcinogenesis 5:1367–1370, 1984
Haidl G, Badura B, Hinsch KD, Ghyczy M, Goreiss J, Schill WB: Disturbances of sperm flagella due to failure of epididymal maturation and their possible relationship to phospholipids. Hum Reprod 8:1070–1073, 1993
Hexsel D, Serra M, Mazzuco R, Dal’Forno T, Zechmeister D: Phosphatidylcholine in the treatment of localized fat. J Dermatol Drugs 2:511–518, 2003
Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RNM, Phillips MJ, Portmann BG, Poulsen H, Scheuer PJ, Schmid M, Thaler H: Histological grading and staging of chronic hepatitis. J Hepatol 22:696–699, 1996
Koizumi J, Kano M, Okabayashi K, Jadhav A, Thompson GR: Behavior of human apolipoprotein A-I:phospholipids and apoHDL:phospholipid complexes in vitro and after injection into rabbits. J Lipid Res 29:1405–1415, 1988
Lay R: Perinatal choline supplementation alters neurothrofic factor and transmitter-specific septohippocampal development. The 7th International Congress of Phospholipids Brussels: Belgium, 1996
Lay R, Heyer CL, Williams MH, Meck MH: Choline-induced spatial memory facilitation correlates with altered distribution and morphology of septal neurons. Adv Exp Med Biol 295:372–382, 1993
Lieber CS, DeCarli LM, Mak KM, Kim C, Leo MA: Attenuation of alcohol- induced hepatic fibrosis by polyunsaturated lecithin. Hepatology 12:1390–1398, 1990
Lieber CS, Robins SJ, Li J, DeCarli LM, Mak KM, Fasulo JM, Leo MA: Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon. Gastroenterology 106:152–159, 1994
Locker J, Reddy TV, Lombardi B: DNA methylation and hepatocarcinogenesis in rats fed a choline devoid diet. Carcinogenesis 7:1309–1312, 1986
Malinow MR: Hyperhomocysteinemia: A common and reversible risk factor for occlusive atherosclerosis. Circulation 81:2004–2006, 1990
McCully KS: Vascular pathology of homocysteinemia. Am J Pathol 56:111–128, 1969
Meck WH: Choline and development of brain memory functions across the lifespan. The 7th International Congress of Phospholipids, Tuesday, September 10, Brussels: Belgium, 1996
O’Brien BC, Andrews VG: Influence of dietary egg and soybean phospholipids and triacylglycerols and human serum lipoproteins. Lipids 28:7–12, 1993
Polichetti E, Janisson A, de la Porte PL, Portugal H, Leonard J, Luna A, La Droitte P, Channussot F: Dietary polyenylphosphatidylcholine decreases cholesterolemia in hypercholesterolemic rabbits: Role of the hepatobiliary axis. Life Sci 67:2563–2576, 2000
Popesko P, Rajtova V, Horak J: A color atlas of the anatomy of the small laboratory animals. Wolfe Publishing Ltd., England, 1990
Rittes PG: The use of phosphatidylcholine for correction of localized fat deposits. Dermatol Surg 27:391–392, 2001
Rittes PG: The use of phosphatidylcholine for correction of lower lid bulging due to prominent fat pads. Aesth Plast Surg 27:315–318, 2003
Rogers AE: Variable effects of a lipotrope-deficient, high-fat diet on chemical carcinogenesis. Cancer Res 35:2469–2474, 1975
Rogers AE: Methyl donors in the diet and responses to chemical carcinogens. Am J Clin Nutr 61:659S–665S, 1995
Saba P, Galeone F, Salvadorini F, Pagliai E, Guidi G, Scalabrino A: Effects of soybean polyunsaturated phosphatidylcholine (Lipostabil) on hyperlipoproteinemia. 24:299–306, 1978
Schneider J, Muller R, Buberl E, Kaffarnik H, Schubotz R, Hausmann L, Muhlfellner G, Muhlfellner O: Effect of polyenylcholine- and clofibrate-induced increase in LDL cholesterol. Eur J Clin Pharmacol 15:15–19, 1979
Shivapurkar N, Wilson MJ, Hoove KL, Mikal YB, Creasia D, Poiner LA: Hepatic DNA methylation and liver tumor formation in male C3H mice fed methionine- and choline-deficient diets. J Natl Cancer Inst 77:213–217, 1986
Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, Tishler PV, Henneckens CH: A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA 268:877–881, 1992
Zeisel SH: Choline: An important nutrient in brain development, liver function, and carcinogenesis. J Am Coll Nutr 11:473–481, 1992
Zeisel SH, Da Costa KA, Franklin PD, Alexander EA, Lamont JT, Sheard NF, Beiser A: Choline, an essential nutrient for humans. FASEB J 5:2093–2098, 1991
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Salles, A.G., Valler, C.S. & Ferreira, M. Histologic Response to Injected Phosphatidylcholine in Fat Tissue: Experimental Study in a New Rabbit Model. Aesth Plast Surg 30, 479–484 (2006). https://doi.org/10.1007/s00266-005-0210-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00266-005-0210-1